Could a diabetes pill ease heart failure in fontan patients?
NCT ID NCT05741658
First seen Jan 06, 2026 · Last updated May 24, 2026 · Updated 20 times
Summary
This study tests whether dapagliflozin, a drug used for diabetes and heart failure, can help adults born with a single ventricle who had Fontan surgery. The goal is to see if it lowers pressure in the veins and improves exercise ability. About 29 adults will take the drug daily for 4 weeks, with regular checkups and tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ronald Reagan UCLA Medical Center
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.